Sick Money

Kenber, Billy

£10.99

The pharmaceutical industry is broken. From the American hedge fund manager who put the price of an AIDS pill up from $13.50 to $750 overnight to the children’s cancer drugs left intentionally to expire in a Spanish warehouse, the signs are all around. A system that was designed to drive innovation and patient care has been co-opted to drive profit. What drugs are being researched, how medicines are priced, who has access to which medicines is now being dictated by share-holder value, not the good of the public – who enjoy ever-diminishing benefits for ever-higher prices. Drugs companies are being fined for bribing doctors in Eastern Europe while patients desperate for life-saving medicines are being driven to the black market in search of drugs the NHS can’t afford. ‘Sick Money’ argues that the way we research medicines and pay for them is no longer working.

Available on backorder

Publish Date: 07/07/2022

Description

THE PHARMACEUTICAL INDUSTRY IS BROKEN

From the American hedge fund manager who drastically hiked the price of an AIDS pill to the children’s cancer drugs left intentionally to expire in a Spanish warehouse, the signs of this dysfunction are all around. A system built to drive innovation and improve patient care has been distorted to maximise profits.

In Sick Money, the investigative journalist who exposed a billion-pound British price-hiking scandal goes inside the global battle over high drug prices. From secret deals to patients forced to turn to the black market, Billy Kenber reveals how medicines have become nothing more than financial assets. He offers a diagnosis of an industry in crisis – and a prescription for how it could be fixed.

Additional information

Weight 287 g
Dimensions 198 × 129 × 26 mm
Author

Publisher

Imprint

Cover

Paperback

Pages

432

Language

English

Edition
Dewey

338.476151 (edition:23)

Readership

College – higher education / Code: F